Lindenwold Advisors Medpace Holdings, Inc. Transaction History
Lindenwold Advisors
- $198 Million
- Q3 2024
A detailed history of Lindenwold Advisors transactions in Medpace Holdings, Inc. stock. As of the latest transaction made, Lindenwold Advisors holds 2,026 shares of MEDP stock, worth $697,085. This represents 0.34% of its overall portfolio holdings.
Number of Shares
2,026
Previous 1,994
1.6%
Holding current value
$697,085
Previous $821,000
17.78%
% of portfolio
0.34%
Previous 0.44%
Shares
12 transactions
Others Institutions Holding MEDP
# of Institutions
623Shares Held
25MCall Options Held
42.8KPut Options Held
207K-
Black Rock Inc. New York, NY2.58MShares$887 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.55MShares$876 Million0.02% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT909KShares$313 Million1.51% of portfolio
-
State Street Corp Boston, MA753KShares$259 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA628KShares$216 Million0.02% of portfolio
About Medpace Holdings, Inc.
- Ticker MEDP
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 31,099,900
- Market Cap $10.7B
- Description
- Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...